Consistent with our hypothesis, DLBCL cells repressed the expression of endothelial markers CD31 and VE-cadherin and stimulated the expression of mesenchymal markers vimentin, FN, and α-SMA. This evidence concerns the gene CDH5 and diffuse large B-cell lymphoma.